Dec09

Final agenda for INVEST 2019 published as MedCity invites speaker applications

The agenda for INVEST 2019 has been finalized as we gear up for our annual flagship conference in Chicago, April 23-24 and invite speakers and startups to apply.

Dec09

Imfinzi looks flimsy in AstraZeneca’s Phase III head and neck cancer study

Results of the Phase III EAGLE study leave Merck’s Keytruda and Bristol’s Opdivo as the dominant players in the space of HNSCC after progression on platinum-based chemotherapy.

Dec09

Texas startup brings in $1.7M for telehealth job marketplace

Enzyme Health, which was founded this year, secured the seed funding from Silverton Partners and private investors.

Dec09

Healthcare spending slows, but still reaches $3.5 trillion

The 3.9 percent jump in spending levels represents a drop from the 4.8 percent increase seen in 2016 and the 5.5 percent hikes seen in 2015 and 2015.

Dec07

San Francisco-based startup Solv’s path to 3 million same-day patient visits

The company’s technology allows patients to book same-day appointments à la OpenTable, pay for medical bills from their phone using and imitate video calls with doctors using their mobile browser.

Dec07

MedCity News StartUPDATES

Funding updates, job changes, and other news from the MedCitizens community.

Dec07

Mayo Clinic collaborates with medication adherence startup MyMeds

Through their partnership, MyMeds users will be able to access medication-related educational content from Mayo Clinic.

Dec07

Moderna raises more than $600M in biggest-ever biotech IPO

The offering closes on Tuesday and follows a string of very large IPOs by biotech companies over the last couple of months. Moderna’s February $500 million Series G round valued the company at $7 billion.